Coya has pioneered the ability to isolate dysfunctional Tregs from a patient, convert them to a highly functional and neuroprotective condition, and expand these cells into the billions for intravenous reinfusion back to the patient
28 June 2021
Neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer’s, and Parkinson’s are...
Read More
07 June 2021
My name is Daniel Barvin and I’m both a Coya Therapeutics employee and a patient intimately tied to neurological...
28 April 2021
One medical appointment at Houston Methodist changed the course of my life. In the middle of my career, I was...